What is your current practice for obtaining mutation status for a patient with newly diagnosed ovarian cancer?  

What specific platforms for determining somatic BRCA and HRD status do you use for a patient who does not carry a germline BRCA mutation?



Answer from: at Community Practice
Comments
Medical Oncologist at Texas Oncology
A very good review incorporating the testing basic...
Medical Oncologist at Arizona Hem/Onc
Excellent review for practicing oncologists. Great...
Sign in or Register to read more

Answer from: at Community Practice

Answer from: Medical Oncologist at Academic Institution